Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study

Por Lau, George, Benhamou, Yves, Chen, Guofeng, Li, Jin, Shao, Qing, Ji, Dong, Li, Fan, Li, Bing, Liu, Jialiang, Hou, Jinlin, Sun, Jian, Wang, Cheng, Chen, Jing, Wu, Vanessa, Wong, April, Wong, Chris L P, Tsang, Stella T Y, Wang, Yudong, Bassit, Leda, Tao, Sijia, Jiang, Yong, Hsiao, Hui-Mien, Ke, Ruian, Perelson, Alan S, Schinazi, Raymond F
Publicado no Lancet Gastroenterol Hepatol (2016)